ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Educational Symposium

Management of RAAS Inhibitor Therapy After Hyperkalemia in Patients with CKD and Heart Failure

November 08, 2025 | 12:45 PM - 01:45 PM

Location: Lanier Grand Ballroom D, Hilton Americas-Houston

Session Description

Patients with CKD and heart failure are at risk for life-threatening hyperkalemia. This symposium reviews RAAS inhibitor therapy after hyperkalemia in patients with CKD and heart failure. Management options are extensively discussed, including dietary and medical therapies. Special attention is paid to the role of potassium binders in this patient population.

Support is provided by an educational grant from AstraZeneca.

Learning Objective(s)

  • Explain the incidence and scope of hyperkalemia in the setting of CKD and heart failure
  • Describe the management of hyperkalemia in the setting of CKD and heart failure

Learning Pathway(s)

  • CKD Non-Dialysis
  • Fluid‚ Electrolyte‚ and Acid-Base Disorders

Moderator

Presentations